Theraskin   Report issue

For profit Phase 2 Phase 3
Founded: São Bernardo do Campo Brazil (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2009
NCT00838812
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Igefarma Laboratorios S.A.

Active Ingredients

Drugs in Phase 3 Trials (2)

clindamycin (cleocin) (1 trial)

tretinoin (Retin-A) (2 trials)

Drugs in Phase 2 Trials (1)

isotretinoin (Accutane) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 3)

Keratosis (Phase 2)

Keratosis, Actinic (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3